Not Signed In -
Acarbose |
Precose |
Acarbose Systematic (IUPAC) name (2R,3R,4S,5R,6R)-5-[(2R,3R,4S,5R,6R)-5- [(2R,3R,4S,5R,6R)-3,4-dihydroxy-6-methyl- 5-[[(1S,4S,5S,6S)-4,5,6-trihydroxy-3-(hydroxy methyl)-1-cyclohex-2-enyl]amino]oxan-2-yl] oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan- 2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol Identifiers CAS number 56180-94-0 ATC code A10BF01 PubChem 441184 DrugBank APRD00656 Chemical data Formula C25H45N3O16 Mol. weight 643.635 g/mol Pharmacokinetic data B ...
Wikipedia - [full article]
Acarbose Clinical Trials
- Acarbose and Secondary Prevention After Coronary Stenting
ClinicalTrials.gov Identifier: NCT00221156 - Recruiting
Glucose Metabolism Disorders; Coronary Artery Disease
- Compare Effect of Acarbose Versus Glibenclamide on Mean Amplitude of Glycemic Excursion and Oxidative Stress in Patients With Type 2 DM Failed to Metformin Monotherapy
ClinicalTrials.gov Identifier: NCT00417729 - Recruiting
Diabetes Mellitus
- The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients
ClinicalTrials.gov Identifier: NCT00437918 - Recruiting
Diabetes Mellitus; Type 2 Diabetes Mellitus
- Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00417950 - Recruiting
Diabetes Mellitus; Impaired Glucose Tolerance
- Effects of Acarbose on Endothelial Function After a Mixed Meal in Newly Diagnosed Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00551954 - Completed
Type 2 Diabetes
- AI(I)DA Acarbose and the Subclinical Inflammation
ClinicalTrials.gov Identifier: NCT00558883 - Completed
Type 2 Diabetes Mellitus; Subclinical Inflammation
email this page
print this page
bookmark this page
feedback on this page
